title: Factor VIII products and inhibitor development: the SIPPET study (survey of inhibitors in plasma-product exposed toddlers).
authors: A. Bianchi Bonomi Hemophilia and Thrombosis Centre, Department of Medicine and Medical Specialties, University of Milan, Italy. pmmannucci@libero.it
authors: P M
authors: PM
authors: Mannucci
authors: A
authors: A
authors: Gringeri
authors: F
authors: F
authors: Peyvandi
authors: E
authors: E
authors: Santagostino
mesh_terms: D001779:Blood Coagulation Factors / Q000032:analysis / Q000627:therapeutic use*; D002675:Child, Preschool; D005169:Factor VIII / Q000276:immunology / Q000627:therapeutic use*; D006467:Hemophilia A / Q000188:drug therapy* / Q000276:immunology*; D006801:Humans; D007223:Infant; D018579:Patient Selection; D016032:Randomized Controlled Trials as Topic; D018401:Sample Size
chemical_list: D001779:Blood Coagulation Factors; C078147:F8 protein, human; D005169:Factor VIII; C065655:anti-inhibitor coagulant complex